AbbVie | ABBV - L'Utile Ante Imposte

Prezzo Delle Azioni
212.34
Cambio Giornaliero
8.45 4.14%
Mensile
-2.37%
Annuale
9.83%
Q2 Previsione
194.46




L'Utile Ante Imposte Cambiamento Data
AbbVie USD 5.57B 2.9B 2026-03
Abbott USD 2.39B 27M 2026-03
ALKERMES USD 100.74M 4.1M 2025-09
Amgen USD 1.51B 2.41B 2025-12
AstraZeneca USD 3.91B 1.28B 2026-03
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Coherus Biosciences USD -46.35M 90.86M 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merck USD 3.42B 3.32B 2025-12
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Novartis USD 4.64B 445M 2025-12
Pacira USD 571K 8.95M 2025-12
Perrigo USD 22.4M 19.2M 2025-09
Pfizer USD 3.33B 290M 2025-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Zoetis USD 887M 15M 2025-09